Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer(Brigham and Women's Hospital), Bertram Pitt(Bayer (Germany)), Brian Claggett(National Heart Lung and Blood Institute), Jerome L. Fleg(National Heart Lung and Blood Institute), Rafael Díaz(Estudios Clínicos Latinoamérica), Sonja M. McKinlay(New England Research Institutes), Eldrin F. Lewis(Brigham and Women's Hospital), Eileen O’Meara(Montreal Heart Institute), John F. Heitner(New York University), Scott D. Solomon(Brigham and Women's Hospital), Susan F. Assmann(National Heart Lung and Blood Institute), Jeffrey L. Probstfield(National Heart Lung and Blood Institute), Nadine Clausell(Universidade Federal do Rio Grande do Sul), Nancy K. Sweitzer(National Heart Lung and Blood Institute), Robin Boineau(National Heart Lung and Blood Institute), Akshay S. Desai(Brigham and Women's Hospital), И. Г. Гордеев(National Heart Lung and Blood Institute), Tamaz Shaburishvili(Shared Health), Sanjiv J. Shah(Northwestern University), Jean L. Rouleau(Montreal Heart Institute), Inder S. Anand(University of Minnesota)
Cited by 1,036
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k